Most Popular Choices
Share on Facebook 25 Printer Friendly Page More Sharing
General News   

Legal ADHD Speed - Becoming Drug Of Choice For Americans

By       (Page 2 of 4 pages) Become a premium member to see this article and all articles as one long page.   1 comment
Message Evelyn Pringle
Panel member, Dr Curt Furberg, recommended that ADHD drugs also come with a patient guide "so that when parents are filling prescriptions for their kids they get a written document laying out the state of knowledge, or lack of the state of knowledge and the potential risks so they are reminded each time that there is a potential risk and we are trying to find solutions to it," he advised.

Since last month's recommendation for a black box warning on cardiovascular events, FDA reviewers announced a recommendation for stronger warnings on all ADHD drugs due to reports of numerous adverse events like mania and psychosis in clinical trials, including modafinil.

On March 14, 2006, an FDA review was posted to the agency's web site in advance of next week's meeting. The FDA said stronger warnings are needed on the risk of psychosis, a mental disorder characterized by the inability to distinguish real and imaginary events.

"The most important finding of this review is that signs of psychosis or mania, particularly hallucinations, can occur in patients with no identifiable risk factors, at usual doses of any of the drugs used to treat ADHD," according to a memo dated March 3 from two members of the agency's ADHD psychiatric review team.

The review said current labeling neither addresses those concerns nor does it "clearly state the importance of stopping drug therapy in any patient who develops hallucinations or other signs or symptoms of psychosis or mania during drug treatment of ADHD."

From January 2000, through June 30, 2005, the review found nearly 1,000 reports of psychosis or mania possibly linked to the drugs, including Adderall, Concerta, Ritalin and Strattera. The reports were pulled from the FDA's database and from the drug makers themselves after the FDA had requested additional information from the drug companies.

The FDA found a "substantial portion of the psychosis-related cases were reported to occur in children 10 years or less," an age group which according to the FDA, does not typically suffer from psychosis.

"The predominance in young children of hallucinations, both visual and tactile, involving insects, snakes and worms is striking and deserves further evaluation," the FDA noted.

Last fall, on September 29, 2005, the FDA issued a public health advisory to alert physicians of reports of suicidal thinking in children and adolescents associated with Strattera, and directed Eli Lilly, manufacturer of Strattera, to develop a Medication Guide for patients and caregivers.

Although Strattera is marketed as a "nonstimulant" medication, according to pediatrician, Dr DuBose Ravenel, MD, FAAP, of Cornerstone Pediatrics, "it is in fact a stimulant every bit as much as the traditional stimulants, as evidenced by even a cursory consideration of its pharmacological action, and evidenced by the fact that it is classified as such by the World Health Organization."

Dr Fred Baughman, ADHD expert and well-known author, will testify before the committee next week on behalf of the International Center for the Study of Psychiatry and Psychology.

"We know these drugs are poisons," Dr Bughman warns, "and we know they are highly addictive, dangerous and sometimes deadly."

He points to the senseless death of children on ADHD drugs. "Matthew Smith is dead today not because of ADHD," he says, "but, as carefully delineated by the medical examiner, his chronic Ritalin/methylphenidate exposure."

"Nor is there any other plausible explanation for the death of Stephanie Hall, 11 years old of Canton, OH," he advises. "No physical predisposing factor other than Ritalin was present," he notes, "leading up to her death, in bed, by cardiac arrhythmia."

"The main question the FDA needs to answer concerns ADHD," Dr Baughman says, "the "disorder" these addictive, dangerous, sometimes deadly drugs are used to treat."

"The shocking fact of the matter is that it is not a disorder/disease at all," he explains, "children said to have it are entirely normal meaning they bear no objective, demonstrable, diagnosable, abnormality, meaning there is no justification for prescribing these or any other drugs for so-called ADHD--a wholly fictitious, wholly subjective entity."

Next Page  1  |  2  |  3  |  4

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Evelyn Pringle Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Glaxo Promotes Mental Disorders - Then Paxil

Government Investigation Finds Autism Vaccine Related

Paxil Five-Year Litigation History

Suicide Risk of Neurontin Kept Hidden for Years

Gambro Healthcare - Dialysis Fraud Pays Big Bucks

Johnson & Johnson Chirate Spinal Disc Under Fire

To View Comments or Join the Conversation:

Tell A Friend